Study of methylation levels of parkin gene promoter in Parkinson's disease patients

International Journal of Neuroscience

Volumn 121, Issue 9, 2011, Pages 497-502

  Cai, Miao ^a   Tian, Jun ^a   Zhao, Guo Hua ^a   Luo, Wei ^a   Zhang, Bao Rong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

CpG sites; Methylation; Parkin; Parkinson's disease; Promoter

Indexed keywords

GENOMIC DNA; PARKIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; PARKINSON DISEASE; PATHOGENESIS; PROMOTER REGION; PROTEIN METHYLATION;

ADULT; CPG ISLANDS; DNA METHYLATION; FEMALE; GENOMICS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROMOTER REGIONS, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 80051524687     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.580866     Document Type: Article

References (22)

1. Agirre, X., Roman-Gomez, J., Vazquez, I., Jimenez-Velasco, A., Garate, L., Montiel-Duarte, C., et al. (2006). Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International Journal of Cancer, 118(8), 1945-1953.
2. Asakawa, S., Tsunematsu, K., Takayanagi, A., Sasaki, T., Shimizu, A., Shintani, A., et al. (2001). The genomic structure and promoter region of the human parkin gene. Biochemical and Biophysical Research Communications, 286(5), 863-868. (Pubitemid 32924852)
3. Cesari, R., Martin, E. S., Calin, G. A., Pentimalli, F., Bichi, R., McAdams, H., et al. (2003). Parkin, a gene implicated in au-tosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proceedings of the National Academy of Science of the United States of America, 100(10), 5956-5961. (Pubitemid 36581860)
4. Clark, L. N., Afridi, S., Karlins, E., Wang, Y., Mejia-Santana, H., Harris, J., et al. (2006). Case-control study of the parkin gene in early-onset Parkinson disease. Archives of Neurology, 63(4), 548-552.
5. de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., et al., (1997). Prevalence of parkinsonism and Parkinson's disease in Europe: The EU-ROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 62(1), 10-15. (Pubitemid 27047434)
6. Denison, S. R., Callahan, G., Becker, N. A., Phillips, L. A., & Smith, D. I. (2003). Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer, 38(1), 40-52. (Pubitemid 36994883)
7. Denison, S. R., Wang, F., Becker, N. A., Schule, B., Kock, N., Phillips, L. A., et al. (2003). Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene, 22(51), 8370-8378. (Pubitemid 37485529)
8. Douglas, M. R., Lewthwaite, A. J., & Nicholl, D. J. (2007). Genetics of Parkinson's disease and parkinsonism. Expert Review of Neu-rotherapeutics, 7(6), 657-666. (Pubitemid 46911615)
9. Esteller, M. (2002). CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene, 21(35), 5427-5440. (Pubitemid 34983479)
10. Gardiner-Garden, M., & Frommer, M. (1987). CpG islands in vertebrate genomes. Journal of Molecular Biology, 196(2), 261-282.
11. Hedrich, K., Eskelson, C., Wilmot, B., Marder, K., Harris, J., Garrels, J., et al.(2004). Distribution, type, and origin of Parkin mutations: Review and case studies. Movement Disorders, 19(10), 1146-1157. (Pubitemid 39429955)
12. Henn, I. H., Gostner, J. M., Lackner, P., Tatzelt, J., & Winklhofer, K. F. (2005). Pathogenic mutations inactivate parkin by distinct mechanisms. Journal of Neurochemistry, 92(1), 114-122. (Pubitemid 40193514)
13. Jones, A. C., Yamamura, Y., Almasy, L., Bohlega, S., Elibol, B., Hubble, J., et al.(1998). Autosomal recessive juvenile parkinson-ism maps to 6q25.2-q27 in four ethnic groups: Detailed genetic mapping of the linked region. American Journal of Human Genetics, 63(1), 80-87. (Pubitemid 30428321)
14. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., et al.(1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392(6676), 605-608. (Pubitemid 28207717)
15. Klein, C., & Schlossmacher, M. G. (2007). Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder. Neurology, 69(22), 2093-2104. (Pubitemid 350175712)
16. Picchio, M. C., Martin, E. S., Cesari, R., Calin, G. A., Yendamuri, S., Kuroki, T., et al.(2004). Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clinical Cancer Research, 10(8), 2720-2724. (Pubitemid 38509147)
17. Staropoli, J. F. (2008). Tumorigenesis and neurodegeneration: Two sides of the same coin? Bioessays, 30(8), 719-727.
18. Wang, F., Denison, S., Lai, J. P., Philips, L. A., Montoya, D., Kock, N., et al.(2004). Parkin gene alterations in hepato-cellular carcinoma. Genes Chromosomes Cancer, 40(2), 85-96. (Pubitemid 38579877)
19. West, A., Farrer, M., Petrucelli, L., Cookson, M., Lockhart, P., & Hardy, J. (2001). Identifcation and characterization of the human parkin gene promoter. Journal of Neurochemistry, 78(5), 1146-1152. (Pubitemid 32823163)
20. West, A. B., Lockhart, P. J., O'Farell, C., & Farrer, M. J. (2003). Identifcation of a novel gene linked to parkin via a bidirectional promoter. Journal of Molecular Biology, 326(1), 11-19. (Pubitemid 36279355)
21. West, A., Periquet, M., Lincoln, S., Lucking, C. B, Nicholl, D., Boni-fati, V., et al.(2002). Complex relationship between Parkin mutations and Parkinson disease. American Journal of Medical Genetics, 114(5), 584-591. (Pubitemid 34680590)
22. Zhang, B. R., Hu, Z. X., Yin, X. Z., Cai, M., Zhao, G. H., Liu, Z. R., et al.(2010). Mutation analysis of parkin and PINK1 genes in early-onset Parkinson's disease in China. Neuroscience Letters, 477(1), 19-22.